Drugs / Acide folinique
Trials 0
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT03584711 Background | Apr 2018 → Mar 2025 | colorectal cancer | Federation Francophone de Cancerologie Digestive | Completed | No outcome recorded |
| Phase 2 | NCT02842580 Background | Sep 2016 → Oct 2020 | colorectal neoplasm | Federation Francophone de Cancerologie Digestive | Terminated | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02494973 Comparator | May 2015 → Mar 2024 | colorectal cancer | Gustave Roussy, Cancer Campus, Grand Paris | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acide folinique | “Acide folinique 400 mg/m² in 2 hours IV (concomitantly to oxaliplatin) D1, followed by 5FU bolus 400 mg/m² in 5-10 minutes IV D1 followed by 5FU 2400 mg/m² IV in 46 hours.” NCT02494973 ↗ |
| Route | Intravenous | “Acide folinique 400 mg/m² in 2 hours IV (concomitantly to oxaliplatin) D1” NCT02494973 ↗ |